T. Rowe Price Investment Management, Inc. Immunome Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 8,275,257 shares of IMNM stock, worth $82 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,275,257
Previous 7,554,594
9.54%
Holding current value
$82 Million
Previous $50.8 Million
51.37%
% of portfolio
0.05%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding IMNM
# of Institutions
148Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
Redmile Group, LLC San Francisco, CA4.87MShares$48.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$46.4 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$44.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$40.4 Million3.27% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$37.3 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $120M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...